Dermatology Times, February 2019 (Vol. 40, No. 2)

In this table, we highlight frequently asked questions about the staging, treatment and surveillance of early-stage melanoma.

Organic and microbiome friendly cosmeceuticals are two big trends to watch out for in 2019, according to this physician. 

Dermatology care for women goes beyond skin. Practicing dermatologists reside at the crux of meeting women’s needs and play an important role in addressing issues like aging, self-esteem, hormones and stress management.

Dermatological conditions that lead to foot pain and discomfort do not necessarily require costly and time-consuming prescription management. Instead, according to a new study, over-the-counter treatments can be a viable option for patients.

For the last several decades, global incidence rates of onychomycosis have risen. This method may be an affordable and effective tool physicians can use to improve diagnosis quickly.

A recent study investigating the association between dietary fat intake and the development of skin cancers found polyunsaturated fat intake especially omega-6 fat to be modestly and consistently associated with skin cancer risk.

Medical practice consultant Debra Phairas offers advice for physicians who are trying to implement practice change.

Looking into the future, dermatologists can anticipate new technologies and treatments to enhance services. In this article, we delve into the how these advances will affect daily workflow.

Healthcare disparities exist in all fields of medicine, including dermatology. We seek to address these disparities in this article by outlining the differences in epidemiology, presentation, access and outcomes of five conditions in patients with skin of color.

A recent survey asks dermatologists who treat patients with moderate to severe psoriasis about the greatest unmet needs of this patient group. Here's what physicians had to say.

The Food and Drug Administration(FDA) approved in December a new drug application for Tolsura (SUBA-itraconazole), a new formulation of itraconazole for the treatment of systemic fungal infections in adults.

In this month's Cosmetic Conundrums, Dr. Zoe Diana Draelos answers questions on hair care, including treatments for dandruff, seborrheic dermatitis and oily hair. 

Novel therapeutic recently completed phase three CAMP-1 and CAMP-2 pivotal trials, demonstrating statistically significant improvements in patients with molluscum contagiosum.

The FDA has approved STP705, an siRNA (small interfering RNA) therapeutic for in situ Squamous Cell Carcinoma Nonmelanoma Skin Cancer (NMSC),  to proceed with phase two clinical trials.

Vyome Therapeutics Inc. announced in January that it secured $22 million in financing to, in part, support the development of its lead molecule, VB 1953, through phase two clinical trials for moderate to severe acne.

Industry relationships are essential for innovation in dermatology. In this month's column, Steve Xu, M.D., and Michael L. Sierra, Ph.D., provide their insight on collaborating with industry.

What can you do if a patient slanders your reputation on social media? David J. Goldberg, M.D.,  J.D., provides his insight in this month's Legal Eagle column. 

Do dermatologists possess the knowledge base to effectively use over-the-counter products? Zoe Diana Draelos, M.D. tackles this question and more in this article.

Ted Rosen, M.D., professor of dermatology at Baylor College of Medicine, Houston, Texas, says a this 61-year-old patient changed the way he thinks about treating moderate-to-severe atopic dermatitis in adults. Share your difficult-to-treat cases with other health care providers on this forum. Participate in this forum.